Evidence map›Paper›PMID 24079972›Full record

ArticleMicrobial cell factories2013

Constitutive expression of selected genes from the pentose phosphate and aromatic pathways increases the shikimic acid yield in high-glucose batch cultures of an Escherichia coli strain lacking PTS and pykF.

Alberto Rodriguez, Juan A Martínez, José L Báez-Viveros, Noemí Flores, Georgina Hernández-Chávez, Octavio T Ramírez, Guillermo Gosset, Francisco Bolivar

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Transcriptional and Metabolic Response of a Strain ofBiotech (Basel (Switzerland)) · 2024
    Article
  5. Glucose Transport inMicroorganisms · 2023
    Review
  6. Article
  7. Artificial cell factory design for shikimate production in Escherichia coli.Journal of industrial microbiology & biotechnology · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Enhancement of NADPH availability for coproduction of coenzyme QJournal of industrial microbiology & biotechnology · 2020
    Article
  13. Metabolic Engineering of Shikimic Acid-ProducingFrontiers in bioengineering and biotechnology · 2020
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Engineering and systems-level analysis ofBiotechnology for biofuels · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alberto RodriguezDepartamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México (UNAM), Apdo, Postal 510-3, Cuernavaca, Morelos 62250, Mexico. gosset@ibt.unam.mx.
Juan A Martínez
José L Báez-Viveros
Noemí Flores
Georgina Hernández-Chávez
Octavio T Ramírez
Guillermo Gosset
Francisco Bolivar
Universidad Nacional Autónoma de México · MXUniversidad Autónoma del Estado de Morelos · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the last two decades many efforts have been directed towards obtaining efficient microbial processes for the production of shikimic acid (SA); however, feeding high amounts of substrate to increase the titer of this compound has invariably rendered low conversion yields, leaving room for improvement of the producing strains. In this work we report an alternative platform to overproduce SA in a laboratory-evolved Escherichia coli strain, based on plasmid-driven constitutive expression of six genes selected from the pentose phosphate and aromatic amino acid pathways, artificially arranged as an operon. Production strains also carried inactivated genes coding for phosphotransferase system components (ptsHIcrr), shikimate kinases I and II (aroK and aroL), pyruvate kinase I (pykF) and the lactose operon repressor (lacI).

resultsThe strong and constitutive expression of the constructed operon permitted SA production from the beginning of the cultures, as evidenced in 1 L batch-mode fermentors starting with high concentrations of glucose and yeast extract. Inactivation of the pykF gene improved SA production under the evaluated conditions by increasing the titer, yield and productivity of this metabolite compared to the isogenic pykF+ strain. The best producing strain accumulated up to 43 g/L of SA in 30 h and relatively low concentrations of acetate and aromatic byproducts were detected, with SA accounting for 80% of the produced aromatic compounds. These results were consistent with high expression levels of the glycolytic pathway and synthetic operon genes from the beginning of fermentations, as revealed by transcriptomic analysis. Despite the consumption of 100 g/L of glucose, the yields on glucose of SA and of total aromatic compounds were about 50% and 60% of the theoretical maximum, respectively. The obtained yields and specific production and consumption rates proved to be constant with three different substrate concentrations.

conclusionsThe developed production system allowed continuous SA accumulation until glucose exhaustion and eliminated the requirement for culture inducers. The obtained SA titers and yields represent the highest reported values for a high-substrate batch process, postulating the strategy described in this report as an interesting alternative to the traditionally employed fed-batch processes for SA production.

Indexed as

BioreactorsEscherichia coliFermentationGlucosePentose Phosphate PathwayPhosphotransferasesPhosphotransferases (Alcohol Group Acceptor)Pyruvate KinaseShikimic AcidGlucosePhosphotransferasesPhosphotransferases (Alcohol Group Acceptor)Pyruvate Kinaseshikimate kinaseShikimic Acid

Identifiers

PMID24079972
PMCPMC3852013
OpenAlexW2109762691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.